You are here:

ciclesonide 80mcg , 160mcg inhaler (Alvesco)


Following an abbreviated submission

ciclesonide inhaler (Alvesco®) is accepted for use within NHS Scotland at high doses (up to 640mcg daily for up to 12 weeks) to control persistent asthma in adolescents and adults (12 years and older).

The higher dose should be used in patients for whom ciclesonide is an appropriate choice of maintenance inhaled corticosteroid therapy. Alternative inhaled steroids are available at lower costs.

Drug Details

Drug Name: ciclesonide 80mcg , 160mcg inhaler (Alvesco)
SMC Drug ID: 412/07
Manufacturer: Altana Pharma Ltd
Indication: Asthma in adolescents and adults (12 years and older)
BNF Category:
Sub Category: 3.3 Cromoglicate and related therapy and leukotriene receptor antagonists
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 12 November 2007